Agoracom Blog

Else Nutrition $BABY.ca Announces Listing on Frankfurt Stock Exchange $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:08 AM on Friday, June 12th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Announce that its common shares were accepted for listing on the Frankfurt Stock Exchange (FSE) under the trading symbol 0YL
  • FSE listing is expected to increase trading liquidity in the Company’s shares, as well as to assist in attracting investment by institutional and retail investors in Europe

VANCOUVER, BC, June 12, 2020 – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQB: BABYF) (FSE: 0YL) (“Else” or the “Company“), is pleased to announce that its common shares were accepted for listing on the Frankfurt Stock Exchange (FSE) under the trading symbol 0YL. The Company’s common shares are now cross-listed on the TSX Venture Exchange, the OTCQB and the FSE. The FSE listing is expected to increase trading liquidity in the Company’s shares, as well as to assist in attracting investment by institutional and retail investors in Europe.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly-traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF. Else’s Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children’s Hospital, ESPGHAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition). Plum Organics, Tel Aviv University’s Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

VIDEO: Datametrex $DM.ca #COVID19 Test Kit Sales Of Approx $1.5M & 26,000 Units – Are Just PILOT PROJECTS

Posted by AGORACOM-JC at 6:43 PM on Thursday, June 11th, 2020

On April 16, Datametrex AI  announced it had obtained the rights to import and sell COVID-19 test kits from South Korea, due to a request for help from the Canadian Government who needed a partner with high-level security clearances.

On May 15, Datametrex AI reported its first sale of $500,000 for 10,000 units to a Canadian mining company.

By today’s interview (June 11) Datametrex has announced approximately $1,500,000 in sales, representing approximately 25,000 COVID-19 test kits.
Any company and their investors would be very happy with these results give the fact it’s Q3 sales (March 31 and Pre-COVID) were $810,000 strictly from Artificial Intelligence.

But CEO Marshall Gunter then dropped a bomb on us …. the ~25,000 Units and $1.5M in COVID-19 test kit sales are PILOT PROJECTS, the definition of which according to QUORA is:

A pilot project is an initial smaller scale implementation of a larger project that is used to work out issues and roadblocks prior to going all out with the full project.

Clearly, Datametrex has something potentially bigger in mind, assuming all goes well with these pilot projects.  How well are they going?  Who else are they talking to?  How far could the “full project” go?

The answers to those questions will come from our latest interview with Datametrex AI CEO, Marshall Gunter.  

Datametrex AI (DM: TSXV) is a great Canadian small cap technology company, who is giving small cap investors an opportunity to participate in the emerging world of Artificial Intelligence, as well as, the brand new world of COVID-19 testing.

Watch this interview or listen by Podcast on Apple, Google, Spotify or your favourite podcaster.

PyroGenesis $PYR.ca Signs Second Modelling Contract with New Iron Ore Pelletization Client $RTN $NOC $UTX $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 1:17 PM on Thursday, June 11th, 2020
  • Signed a second multi-phase torch modelling contract aimed at evaluating the performance of PyroGenesis’ proprietary torches in an existing iron ore industrial furnace with the goal of replacing existing fossil fuel burners with PyroGenesis’ plasma torches
  • The first phase is expected to be completed in approx. 8 to 10 weeks
  • This Contract is with another multi-billion-dollar producer of iron ore pellets (“ClientB”), whose name will remain confidential for competitive reasons
  • ClientB has over 100 burners in its existing facilities

MONTREAL, June 11, 2020 – PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, is pleased to announce today that, further to its press releases dated March 4th, April 30th and May 19th, 2020, it has signed a second multi-phase torch modelling contract (the “Contract”), aimed at evaluating the performance of PyroGenesis’ proprietary torches in an existing iron ore industrial furnace with the goal of replacing existing fossil fuel burners with PyroGenesis’ plasma torches. The first phase is expected to be completed in approx. 8 to 10 weeks. This Contract is with another multi-billion-dollar producer of iron ore pellets (“ClientB”), whose name will remain confidential for competitive reasons. ClientB has over 100 burners in its existing facilities.

“This is the second press release announcing that a significant player in the iron ore pelletization industry has entered into a modeling contract with us, in the past few months,” said Mr. Peter Pascali, CEO and President of PyroGenesis. “This just underscores the tremendous impact our proprietary torch is having on the industry and, as we said in the past, this interest is spilling over into other industries as well (such as mining, metallurgy and cement industries). We continue to find that the proposition of reducing greenhouse gases emissions, and avoiding carbon taxes, with a simple bolt-on replacement of their current environmentally damaging fossil fuel burners, is too compelling to resist.  That, combined with the environmental pressure these industries are currently under (only recently a new trend has emerged where financial institutions are tying credit facilities and debt issuances to carbon reduction targets for multi-national industrial and mining conglomerates), has contributed significantly to this wave of interest and proposals.”

“In fact, it goes beyond avoiding carbon taxes,” said Mr. Pierre Carabin, CTO of PyroGenesis. “We see a global trend towards a zero-carbon economy, with the push coming not only from regulators but also from shareholders, investment funds and the general population.  As such, all the industry players we are talking to have aggressive internally set carbon reduction targets and are actively seeking commercially ready technical solutions that will have a minimal impact on their operations.  As such, we believe that PyroGenesis’ proprietary torches offer a relatively easy upgrade to existing industrial processes, such as with pelletizing furnaces, while offering major greenhouse gas reductions.  This is in addition to (i) the reduction in pollution from sulfur compounds and heavy metals resulting from heavy fuel oil burners, and (ii) a cost advantage to those companies that have access to affordable hydro power as a replacement to expensive bunker fuel.”

This modelling contract, once again, is geared to demonstrating that replacing fossil fuel burners with PyroGenesis’ proprietary plasma torches will not have any detrimental effects on ClientB’s process or their furnaces. Both ClientB and the Company do not anticipate any detrimental effects. As previously disclosed,  for a separate iron ore pelletization Client (“ClientA”), replacing fossil fuel burners with  PyroGenesis’ proprietary plasma torches could theoretically result in a CO2 reduction in excess of 350,000 tons per year per plant (which is equivalent to removing 76,000 cars1 from the road), while at the same time projecting significant cost savings. In the case of ClientB, the switch to plasma torches will also result in the additional benefit of significantly reducing the emission of another pollutant; sulfur dioxide (SO2).

“Although, there is no guarantee of successful conclusion, nor of the timeframe in which this might occur, given our significant plasma expertise, our specific knowledge of the application, and the challenges in these industries, we are highly confident that there will be a positive outcome as a result of these modeling contracts in the very near future,” noted Mr. Pascali. “If and when this outcome is eventualized, PyroGenesis will execute it in a very conservative, strategic and determined manner, with the primary goal being to maximize customer satisfaction and shareholder value. Everything will be geared to securing success, market penetration, and ensuring PyroGenesis’ long-term viability as the preeminent supplier of torches to the industry. Our proprietary position, built upon a strong process patent, provides us with a significant advantage in pursuing this goal.”

Although there is no guarantee of future contracts, PyroGenesis has already not only contacted its existing suppliers in anticipation of any orders of size, but is also actively expanding their supplier base to mitigate any supply chain risk of significant orders. PyroGenesis’ management is confident that the Company is now well positioned to address any anticipated demand.

Pelletization is the process in which iron ore is concentrated before shipment, thus significantly reducing the cost of transportation. In conventional technologies, the process heat is provided by fuel oil or natural gas burners (both environmentally damaging). The combustion, in the burners, of fossil fuels results in the production of greenhouse gases, mainly CO2. Plasma torches, by contrast, utilize renewable electricity and as such offer an environmentally attractive alternative to fossil fuel burners.

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development
Phone: (514) 937-0002, E-mail: [email protected]

VIDEO: ImagineAR $IP.ca #AR, “Sports 2.0” & TikTok – NEXT SUPER STOCK Livestream 6/10/20 $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 11:56 AM on Thursday, June 11th, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

Why Imagine AR?

(IP:CSE) (IPNFF:OTCQB)

  • ImagineAR Has Already Started Commercializing Its Augmented Reality Platform
  • Clients Include: 
    • NBA Sacramento Kings
    • Mall of America
    • AT&T Shape
    • Basketball Hall Of Fame
    • Milwaukee AutoShow
  • Microsoft Authorized Co-Sell Partner
  • Closed Major Financing In Q1 2020
  • Enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience
  • ImagineAR is now well positioned to further commercialize and capitalize on massive demand for Augmented Reality
  • Signed five year $300,000USD licensing agreement with SlapItOn to provide Augmented Reality for athletes and celebrities to engage fans
  • Announced partnership with Engaged Nation, an award winning leader in digital engagement marketing for Casinos
  • Announced partnership with North Highland, a top ranked global consulting firm with over 5,000 consultants and 70 offices around the world
    • North Highland was ranked on the Forbes 2020 America’s Best Management Consulting Firms list, placing in seven categories, including one of only 31 firms ranked for Internet, Media and Entertainment.

Loncor Files NI 43-101 Technical Report on Imbo Project, Confirming Inferred Mineral Resource Increase to 2.5 Million Ounces $LN.ca $ABX.ca $TECK.ca $RSG $NGT.to $GOLD $NEM

Posted by AGORACOM at 10:07 AM on Thursday, June 11th, 2020
  • The Imbo inferred mineral resource increased by 49% to 2.5 million ounces (30.65 million tonnes grading 2.54 g/t Au). 76.29% of this gold resource is attributable to Loncor via its 76.29% interest in the Imbo Project.
  • 76.29% of this gold resource is attributable to Loncor via its 76.29% interest in the Imbo Project.
  • A planned drill program will look to add to the Adumbi resource over the next twelve months.

TORONTO, June 10, 2020 (GLOBE NEWSWIRE) — Loncor Resources Inc. (“Loncor” or the “Company“) (TSX: “LN”; OTCQB: “LONCF”) announces that it has filed on SEDAR an independent National Instrument 43-101 technical report (the “Technical Report”) relating to the Company’s Imbo Project, in particular, the updated gold mineral resource estimates for the Imbo Project reported in the Company’s April 17, 2020 press release.  The Technical Report, which was prepared by Minecon Resources and Services Limited, has an effective date of April 17, 2020 and is entitled “Independent National Instrument 43-101 Technical Report on the Imbo Project, Ituri Province, Democratic Republic of the Congo”.

Highlights from April 17, 2020 press release confirmed in Technical Report:

  • The Imbo Project inferred mineral resource increased by 49% to 2.5 million ounces of gold (30.65 million tonnes grading 2.54 g/t Au).  76.29% of this gold resource is attributable to Loncor via its 76.29% interest in the Imbo Project. 
  • Within the Imbo Project, the Adumbi deposit inferred mineral resource increased by 61% to 2.19 million ounces of gold (28.97 million tonnes grading 2.35 g/t Au) (the Adumbi deposit is one of the three deposits at Imbo currently with a resource). 
  • A planned drill program will look to add to the Adumbi resource over the next twelve months.

The Imbo mineral resources are in addition to Loncor’s resources at its Makapela Project (which is 100%-owned by Loncor) where there is an indicated mineral resource of 614,200 ounces of gold (2.20 million tonnes grading 8.66 g/t Au) and an inferred mineral resource of 549,600 ounces of gold (3.22 million tonnes grading 5.30 g/t Au). 

Arnold Kondrat, CEO of Loncor, stated: “This filing of the 43-101 represents the culmination of many years of persistence by the Loncor team in the Ngayu greenstone belt.  We believe this region is one of the few remaining areas around the world where Tier 1 gold deposits can still be discovered, built and mined profitably as shown by Barrick Gold at the Kibali mine.  Over the next 12 months, Loncor will look to drive forward with a drill program at the Adumbi deposit, with the aim of significantly increasing the current resource, while simultaneously awaiting with interest news on the imminent drilling program at the drill targets defined by our Joint Venture partner Barrick Gold.”

About Loncor Resources Inc.
Loncor is a Canadian gold exploration company focussed on the Ngayu Greenstone Belt in the North East of the Democratic Republic of the Congo (the “DRC”).  The Loncor team has over two decades of experience of operating in the DRC.  Ngayu has numerous positive indicators based on the geology, artisanal activity, encouraging drill results and an existing gold resource base.  The area is 220 kilometres southwest of the Kibali gold mine, which is operated by Barrick Gold (Congo) SARL (“Barrick”).  In 2019, Kibali produced record gold production of 814,000 ounces at “all-in sustaining costs” of US$693/oz.  Barrick has highlighted the Ngayu Greenstone Belt as an area of particular exploration interest and is moving towards earning 65% of any discovery in 1,894 km2 of Loncor ground that they are exploring.  As per the joint venture agreement signed in January 2016, Barrick manages and funds exploration on the said ground at the Ngayu project until the completion of a pre-feasibility study on any gold discovery meeting the investment criteria of Barrick.  In a recent announcement Barrick highlighted six prospective drill targets and are moving towards confirmation drilling in 2020. Subject to the DRC’s free carried interest requirements, Barrick would earn 65% of any discovery with Loncor holding the balance of 35%.  Loncor will be required, from that point forward, to fund its pro-rata share in respect of the discovery in order to maintain its 35% interest or be diluted.

In addition to the Barrick JV, certain parcels of land within the Ngayu project surrounding and including the Makapela and Adumbi deposits have been retained by Loncor and do not form part of the joint venture with Barrick. Barrick has certain pre-emptive rights over the Makapela deposit.  Loncor’s Makapela deposit (which is 100%-owned by Loncor) has an indicated mineral resource of 614,200 ounces of gold (2.20 million tonnes grading 8.66 g/t Au) and an inferred mineral resource of 549,600 ounces of gold (3.22 million tonnes grading 5.30 g/t Au).  Adumbi and two neighbouring deposits hold an inferred mineral resource of 2.5 million ounces of gold (30.65 million tonnes grading 2.54 g/t Au), with 76.29% of this resource being attributable to Loncor via its 76.29% interest in the project.  

Resolute Mining Limited (ASX/LSE: “RSG”) owns 26% of the outstanding shares of Loncor and holds a pre-emptive right to maintain its pro rata equity ownership interest in Loncor following the completion by Loncor of any proposed equity offering. 

Additional information with respect to Loncor and its projects can be found on Loncor’s website at www.loncor.com.

Qualified Person
Peter N. Cowley, who is President of Loncor and a “qualified person” as such term is defined in National Instrument 43-101, has reviewed and approved the technical information in this press release. 

Technical Reports
Additional information with respect to the Company’s Imbo Project is contained in the technical report of Minecon Resources and Services Limited dated April 17, 2020 and entitled “Independent National Instrument 43-101 Technical Report on the Imbo Project, Ituri Province, Democratic Republic of the Congo”.  A copy of the said report can be obtained from SEDAR at www.sedar.com. 

$KABN.ca Systems NA – The Company that’s Protecting Identity as YOUR Basic Human Right

Posted by AGORACOM-JC at 10:01 AM on Thursday, June 11th, 2020
This image has an empty alt attribute; its file name is image-3.png

While investing in small cap companies comes with certain inherent risks, it’s not high stakes, low chance gambling. In fact, practically every billion-dollar large cap company started off as a penny stock.

For the savvy retail investor or day trader, they know full well that emerging financial technology-based companies have, for the past two decades-plus, offered the highest returns with relatively low risk mitigation…even despite the dot com bubble crash of the early 2000’s.

Today, a lot of smart money is funneling into forward-thinking companies that are fulfilling an immediate need to provide real world solutions to identity fraud and creating value through data validation.

Now, an innovative, Toronto-based company is making real things happen to protect consumers, companies, and capital.

KABN (pronounced ‘Cabin’) Systems NA (CSE:KABN, Forum) is already on the forefront of developing cutting-edge blockchain-supported and biometric customized identity solutions software. Bear in mind, this fintech company is not in conflict or cooperation with companies trying to use your data. They are the protectors of your data. Here’s how they do it.

Their world-class suite of products and services work seamlessly across all channels and, most importantly, all demographic groups. Simply put, KABN’s software apps and digital banking processes can work for everyone.

KABN works differently than other companies in this space. How? They offer a unique, comprehensive, and integrated suite of identity, financial, and loyalty services.

Here’s the starting lineup. Liquid Avatar – powered by KABN ID – provides an ‘Always On’, biometrically-based, privacy-compliant, identity validation and verification platform which enables users to continuously and confidently prove themselves to the online community, exchanges, and other services. KABN ID is the backbone to its financial, loyalty, and engagement solutions including the KABN Prepaid Card program and KABN KASH – an innovative cash-back program where users are connected to online merchants for savings when they shop.



(Click image to enlarge. *Estimates are for the North American market ONLY.)


Why Digital Identity Matters

Identity is what makes people unique, but since the inception of the internet, digital identity has often been an afterthought. With today’s acceleration of online commerce, education, healthcare, government, and other services tailored to the individual, digital identity and the data that surrounds it is online “gold”. KABN says they believe that ownership of identity is a “basic human right and individuals should be the primary beneficiary of any use of their identity.” This is what sets KABN apart.

In the conventional world, it’s easy to prove who you are either by visual or traditional identity verification. It’s a process that most people are accustomed to following.

In today’s digital world, it’s not that easy to prove “you are you”. Identity verification is managed on a site-by-site basis and users are often required to deliver sensitive documents to unknown third parties, potentially reducing the value of their identity and increasingly exposing themselves to the risk of identity fraud.“KABN believes that ownership of identity is a basic human right and individuals should be the primary beneficiary of any use of their identity.”Digital Identity “Friction”

In the digital data world, it’s all about the pennies, nickels, dimes, and quarters and the
ability to passively and actively generate revenues through everyday consumer activities. The Company says that, at present, the digital identity space has not satisfactorily addressed both the consumer and commercial stakeholder needs. Both are vital to consider, and these include:

Consumer Identity Needs…

  • to make ID verification reusable
  • to put me in control of my private data
  • to help me manage my public data
  • to reduce identity fraud

Commercial Identity Needs…

  • to reduce friction of screening consumer users
  • to simplify user verification
  • to streamline compliance resources
  • to manage user Personally Identifiable Information (PII) efficiently

KABN’s Suite of Solutions: KABN ID, Liquid Avatar, the KABN Prepaid Visa card, and KABN KASH.

KABN ID

KABN ID is a proprietary, blockchain, and biometrically-based digital identity verification platform for both commercial clients and consumers users. KABN ID is a complete shift in thinking for identity validation as KABN ID provides a reusable, bank-grade identity verification for the individual user, at no cost to the consumer.

KABN ID is a global 24/7/365 verified online ID that is controlled by the client. The online identity service that is regulatory compliant, blockchain and biometrically-based, and is available at no cost to the consumer.

Users own and control the use of their verified identification, no personally identifiable information is ever transferred without authorization, and it provides organizations with an “Always On” KYC / AML (Know Your Customer / Anti Money Laundering) validation and verification process.

Liquid Avatar

Data is indeed the new “gold”. As users are presented value offerings and other services based on their public data profiles and system generated data, KABN, in turn, offers information services that are delivered directly to the user. User data is never sold or rented and remains part of the KABN Network.

A Liquid Avatar is a multi-layered, visual technology icon or token that contains information that can be linked, authenticated, and shared. When you share a Liquid Avatar, you automatically attach public data that will allow permission-based private data to be authenticated.

Liquid Avatars include a Visual or Presentation Layer – Public Data Layer, Private Data Layer, and a Security and Authentication Layer.

KABN Prepaid Visa Card

As part of KABN’s commitment to providing its Customers with innovative, permission-based values, KABN is introducing its first financial services program, the KABN Prepaid Visa card and Mobile Banking Wallet program that supports both digital and traditional currencies.

KABN Prepaid Visa cardholders will be able to spend in-store, online, and access ATMs globally, wherever Visa is accepted.

KABN Card Features include:

  • a digital currency-linked prepaid Visa card
  • a multiple currency banking wallet
  • KABN KASH cashback program and other innovative services

and, global access – anywhere that Visa is accepted worldwide.

KABN KASH

KABN KASH is a robust engagement portal which includes a cash-back program. Here users are able shop at some of North America’s top online merchants and receive cash back on their KABN Card. Customers will also receive updates on special offers and unique deals exclusive to KABN KASH.

KABN KASH Features include:

  • an exclusive customer portal
  • cashback rewards
  • special offers
  • exclusive opportunities & experiences
  • and instant savings alert messaging.

In the News: “KABN Systems to take over Torino Power Solutions”

Kabn Systems North America – a fintech company leveraging biometric ID verification – has signed an agreement with Torino Power Solutions to execute a reverse takeover (RT) as it prepares to launch a digital banking and financial services platform.

The platform will consist of continuous ID validation and verification processes. These include:

  • Liquid Avatar – powered by KABN ID – which is based on biometrics and blockchain
  • the KABN Prepaid Visa Card, which acts as a payment card and digital wallet for multi-currency transactions with digital or fiat currencies
  • and KABN KASH, a loyalty and customer engagement platform.

The technology is just not cool…it’s comprehensive.

From the Executive Team

In a lively and informative interview with Stockhouse Editorial, KABN’s Chief Executive Officer, Ben Kessler talked about a variety of timely Company happenings, including not only the experience but the innovative ideas they’re bringing to the digital identity management space. Ben Kessler commented:

“Our focus is on our three core strengths – Reach, a Unique Business Approach and Team. With our senior management team, I think the great thing we all bring is some extremely strong skillsets and experiences and we all see things, in some ways, slightly different. And that’s a good thing.”

Kessler also highlighted the three unique attributes that he believes will make KABN successful:

“First, our reach. It covers 100 percent of the addressable online market which is approximately 300 million people in North America, so we don’t have to go looking to provide a service to people who may not want it. Identity is becoming more important. Second, we have a unique business approach. We want to empower consumers to manage and control their identity and find ways to create value and opportunity from that identity. Our business is to empower constituents and commercial clients, as well. The third thing is, we’ve just got a simply outstanding team. We’ve all been doing this for a lot of years and in my career, I’ve never had a better crew of people that I’ve ever worked with. We’ve got a great team and advisors that are all uniquely focussed on succeeding.”

In Closing

There aren’t a lot of companies like KABN that offer a unique ground-floor investment opportunity in one of the most vital sectors of the New Economy – digital identity protection. The team says they’re excited and completely engaged in doing what’s best for investors, and it shows. Afterall, isn’t that what it’s all about? Bringing ‘value and opportunity’ to one of the most blue-sky digital global markets available today.

Source: https://stockhouse.com/news/newswire/2020/06/11/the-company-that-s-protecting-identity-as-your-basic-human-right

Psilocybin Seems to Turn Down the “Ego Center” in Brain SPONSOR: MOTA Ventures $MOTA.ca $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 9:52 AM on Thursday, June 11th, 2020

SPONSOR: Mota Ventures Corp is an established natural health products company focused in the CBD and psychedelic medicine sectors. Through their powerful eCommerce business, Mota is a leading direct-to-consumer provider of a wide range of natural health products throughout the United States and Europe. Click Here for More Info

In a new study, Johns Hopkins Medicine researchers analyzed the brain scans of people after they took psilocybin, the active compound in psychedelic (magic) mushrooms, to see what happens in the brain when people are on psychedelics.

The team focused on a part of the brain known as the claustrum, taken from the Latin word for “hidden or shut away.” The claustrum is an extremely thin sheet of neurons deep within the cortex, yet it reaches out to every other region of the brain.

Its true purpose remains “hidden away” as well, with researchers speculating about its functions. For example, Dr. Francis Crick, the British biologist and neuroscientist who proposed the double helix structure of the DNA molecule, believed that the claustrum was the seat of consciousness, responsible for awareness and sense of self.

What is known is that this region contains a large number of receptors targeted by psychedelic drugs such as LSD or psilocybin.

To see what happens in the claustrum when people are on psychedelics, the researchers compared the brain scans of people after they took psilocybin with their scans after taking a placebo.

The scans after psilocybin use showed that the claustrum was less active, meaning the area of the brain believed responsible for setting attention and switching tasks is turned down when on the drug.

The researchers say that this ties in with what people report as typical effects of psychedelic drugs, including feelings of being connected to everything and reduced senses of self or ego.

“Our findings move us one step closer to understanding mechanisms underlying how psilocybin works in the brain,” says Frederick Barrett, Ph.D., assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine and a member of the school’s Center for Psychedelic and Consciousness Research.

“This will hopefully enable us to better understand why it’s an effective therapy for certain psychiatric disorders, which might help us tailor therapies to help people more.”

Because of its deep-rooted location in the brain, the claustrum has been difficult to access and study. Last year, Barrett and his colleagues at the University of Maryland, Baltimore, developed a method to detect brain activity in the claustrum using functional magnetic resonance imaging (fMRI).

In this study, the researchers used fMRI with 15 people and observed the claustrum brain region after the participants took either psilocybin or a placebo. They found that psilocybin reduced neural activity in the claustrum by 15% to 30%.

This reduced activity also appeared to be linked to the stronger subjective effects of the drug, such as emotional and mystical experiences. The team also found that psilocybin changed the way that the claustrum communicated with brain regions involved in hearing, attention, decision-making and remembering.

With the highly detailed imaging of the claustrum provided by fMRI, the researchers hope to look at this mysterious brain region in people with certain psychiatric disorders such as depression and substance use disorder.

The aim of this research would be to see what roles, if any, the claustrum plays in these conditions. The team also plans to observe the claustrum’s activity when under the influence of other psychedelics, such as salvinorin A, a hallucinogen derived from a Mexican plant.

The findings are published online in the journal NeuroImage.

Source: Johns Hopkins Medicine

https://psychcentral.com/news/2020/06/06/psilocybin-seems-to-turn-down-ego-center-in-brain/157165.html

Eyecarrot $EYC.ca Appoints Dr. Jason Dyck and Dr. Sandra Stoddard to the Scientific Advisory Board $EYPT $KALA

Posted by AGORACOM-JC at 9:07 AM on Thursday, June 11th, 2020
http://www.smallcapepicenter.com/eyc%20square.png
  • Announcd the appointment of Dr. Jason Dyck and the appointment of Dr. Sandra Stoddard to the company’s Scientific Advisory Board

TORONTO, ON and NEW YORK, NY / June 11, 2020 / Eyecarrot Innovations Corp (TSXV:EYC)(QTCQB:EYCCF)(2EYA:GR) is pleased to announce the appointment of Dr. Jason Dyck and the appointment of Dr. Sandra Stoddard to the company’s Scientific Advisory Board.

About Dr. Jason Dyck

Dr. Jason Dyck is a world-class research scientist and professor in the Department of Pediatrics at the University of Alberta, the director of the University of Alberta Cardiovascular Research Centre, a Canada Research Chair in Molecular Medicine, and a fellow of the Canadian Academy of Health Sciences. Dr. Dyck also has a wealth of experience in establishing and directing large interdisciplinary research teams, which provides the strongest foundation for credible and useful research to reach key stakeholders and improve healthcare and health outcomes.

Dr. Dyck has published over 220 peer-reviewed papers and is a recognized expert in basic biomedical research, which has attracted international recognition and has contributed to him being invited to co-chair the National Research Council for Diabetes Canada, and to serve on the Editorial boards of 4 major international journals. Dr. Dyck also reviews grants for international granting bodies such as The National Aeronautics and Space Administration (NASA), the National Institute for Health (NIH), the Welcome Trust, the National Health and Medical Research Council of Australia, the Dutch Diabetes Research Foundation and the European Research Council. Dr. Dyck was recognized as one of Canada’s Top 40 under 40 (awarded by the Caldwell Partners).

“I’m excited by this opportunity to learn from the Eyecarrot team and to assist the science advance to the clinical testing phase for both educational purposes and sports medicine applications. I am impressed with the passion that Adam brings to this company and with this new team that he has assembled. Working alongside Mr. Booth again in this capacity is important because he has the passion, vision and experience to help this company achieve its goals,” stated Dr. Jason Dyck PhD, Eyecarrot Scientific Advisory Board.

Dr. Dyck has a track record of excellence at all levels, and his background in research, leadership, and business development are key attributes that will help drive the scientific backing and product offerings included in the Binovi Platform,” commented Adam Cegielski, Eyecarrot CEO.

As Chief Scientific Officer, I welcome the scientific perspectives of accomplished researchers such as Dr. Dyck”, added Dr. Leonard Press, newly appointed Eyecarrot CSO.

About Dr. Sandra Stoddard

Dr. Sandra Stoddard is a distinguished educator who has devoted her entire 32-year career to ensuring her personal vision: success for all students. For Dr. Stoddard, this is not just a statement, but a passion. She holds a Bachelors of Education, a Masters in Educational Psychology in the area of Mild and Moderate Disabilities and a PhD in Educational Psychology. She was the recipient of the Nadene M. Thomas Graduate Research Bursary for her PhD Dissertation: Predicting First-Year Teaching Proficiency.

Throughout her career, Dr. Stoddard has served in many capacities including teacher, educational consultant, assistant principal, principal, director and executive director. She is currently the Associate Superintendent of a public-school division and oversees Early Learning, Inclusive Learning, Curriculum and Instructional Supports, Information Technologies, as well as all the Elementary schools within the Division. Outside of the Educational arena, Dr. Stoddard served as the Senior Manager of the Innovation and Improvement Unit, Research and Innovation Branch, within the Government of Alberta. In this role, she established and led a unit responsible for a variety of initiatives that involved partnerships with other Ministries, community agencies, private sector organizations, provincial associations, and academic institutions, all with the aim of engaging communities and individuals to improve support and services to Alberta’s vulnerable children, youth, and families. During this role, she was a recipient of the Premier’s Award of Excellence.

At the international level, Dr. Stoddard served as a Board of Director for the Association for Supervision and Curriculum Development (ASCD), a global organization comprised of 115,000 members in more than 128 countries, working to pursue excellence in learning, teaching and leading. As a result of meeting with education and government officials in numerous countries, she is fully aware of issues in education that are international in scope which will enhance our ability to potentially contribute to positive educational outcomes on a global level.

“I am excited to be a part of Eyecarrot and integrating Binovi into practice. Preliminary research suggests that vision therapy can be used to improve reading fluency, reading comprehension and other educational outcomes. For far too long, education has been working in a silo to try to address educational challenges. The impact of integrating medical and educational research, to support success for all students, has the potential to be transformational,” stated Dr. Sandra Stoddard B.Ed, M.Ed, PhD, Eyecarrot Scientific Advisory Board.

“Dr. Stoddard’s wealth of experience in integrating educational theory into practice will be an asset to the company as we collaborate, to improve educational outcomes for students,” commented Eyecarrot CEO Adam Cegielski.

Vision is an integral component of learning, and I look forward to working with Dr. Stoddard on optimizing the transfer of visual abilities to the educational environment”, noted Dr. Leonard Press, Chief Scientific Officer of Eyecarrot.

In addition to the affirmation of Dr. Dyck and Dr. Stoddard to the Scientific Advisory Board, Mr. Terry Booth, Founder and former CEO of Aurora Cannabis (ACB), was appointed as the Company’s Executive Chairman. Mr. Booth skillfully raised Aurora from its infancy into one of the world’s largest and fastest growing cannabis companies, valued at $18B at its peak, with a focus on providing high-quality medical and adult usage cannabis and inspiring better days for medical and recreational consumers around the world. Mr. Booth is instrumental in coordinating the contributions of Dr. Jason Dyck and Dr. Sandra Stoddard to the expansion of Eyecarrot’s Binovi Platform.

The company is driven to leveraging expert knowledge as part of the development, expansion, and delivery of the Binovi Platform to clients in all industries, from education, to sports, to optometry, and beyond.

Please visit https://www.eyecarrot.com/investors/ for additional information on the Company.

About Eyecarrot Innovations Corp (EYC)

Eyecarrot is a human performance technology company that has developed Binovi, a hardware and software-centered platform. Binovi combines hardware, software, specialized expert knowledge, and unique big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of skills related to human performance. We are working together under a common banner to help neuro-optometry, vision rehabilitation, and vision performance professionals gain measurable results in less time, and with less effort.

On behalf of the Board of Directors

Adam Cegielski

President | CEO

Investor Relations

Email: [email protected]
Toll-free: 1 (844) 866-6162
https://www.eyecarrot.com/investors/

Forward looking information

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com. The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

$HPQ.ca Silicon Enters Into Confidential Technical Discussions With an Advanced Material Developer Regarding Energy Storage Applications $FSLR $SPWR $CSIQ $PYR.ca $XMG.ca

Posted by AGORACOM-JC at 8:41 AM on Thursday, June 11th, 2020
  • HPQ has signed a non-disclosure agreement with an advanced materials developer for the purposes of exchanging technical information and sending silicon samples produced by the PUREVAP™Â Nano Silicon Reactor (NSIR) for energy storage applications testing
  • For industry competitive reasons, and according to the terms of the NDA, the identity of the advanced materials developer must remain confidential

MONTREAL, June 11, 2020 — HPQ Silicon Resources Inc. (“HPQ” or the “Company”) TSX-V: HPQ; FWB: UGE; Other OTC : URAGF; is pleased to announce that HPQ has signed a non-disclosure agreement (“NDA”) with an advanced materials developer for the purposes of exchanging technical information and sending silicon samples produced by the PUREVAP™Â Nano Silicon Reactor (NSIR) for energy storage applications testing. For industry competitive reasons, and according to the terms of the NDA, the identity of the advanced materials developer must remain confidential.

“This NDA is further indications that the game changing potential of the PUREVAP™ NSiR process we are developing with PyroGenesis Canada Inc. (TSX-V: PYR) is attracting interest from participants involved in the energy storage race. Being able to start technical discussions before producing samples is an incredible advantage, as it allows us to better match our material characteristics with what market participants are looking for,” said Bernard Tourillon, President and CEO HPQ Silicon. “Silicon’s potential to meet energy storage demand is undeniable and generating massive investments, and serious industry interest, so our timing could not be better. Suffice it to say, we are very pleased to continue attracting such early interest. However, I must caution investors that although this agreement does signal the interest in our unique products, we are still at the very preliminary stages and there is no guarantee that anything of commercial value will materialize from these efforts. It does however demonstrate the potential for new and exciting advances by HPQ in the silicon energy space.”

GAME CHANGING POTENTIAL OF OUR PUREVAP™ NANO SILICON (Si) REACTOR GETTING NOTICED

Nano Silicon (Si) Powders have been identified as the key element that will allow the manufacture of high-performance Li-ion batteries to deliver on the research promises of an almost tenfold (10x) increase in the specific capacity of the anode, inducing a 20-40% gain in the energy density of Li-ion batteries. The PUREVAP™ NSiR process is purposely being developed to address the fact that current manufacturing processes to make Nano Silicon (Si) Powders are not very scalable and simply too expensive to be commercially feasible, requiring up to US$ 30,000/kg1 selling prices to justify production.

GLOBAL ENERGY STORAGE MARKET READY TO EXPLODE

A recent report by Wood Mackenzie Power & Renewable’s Report projects that energy storage deployments are estimated to grow 1,300% from a 12 Gigawatt-hour market in 2018 to a 158 Gigawatt-hour market in 2024. Meanwhile, at current growth rates of 2% per year, global energy consumption will be an estimated 125,000 Terawatt-hours, which is 800,000 times more than the estimated storage capacity. An estimated US$71 billion in investments will be made into storage systems where batteries will make up the lion’s share of capital deployment

_______
1 Source: Quotation from a producer (Confidential), Media article

About Silicon

Silicon (Si), also known as silicon metal, is one of today’s strategic materials needed to fulfil the Renewable Energy Revolution (“RER”) presently under way. Silicon does not exist in its pure state; it must be extracted from quartz (SiO2), in what has historically been a capital and energy intensive process.

About HPQ Silicon

HPQ Silicon Resources Inc. (TSX-V: HPQ) is a Canadian producer of Innovative Silicon Solutions, based in Montreal, building a portfolio of unique high value specialty silicon products needed for the coming RER.

Working with PyroGenesis Canada Inc. (TSX-V: PYR), a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:

  • The PUREVAP™ â€œQuartz Reduction Reactors” (QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential;
    °  HPQ believes it will become the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon metal (3N – 4N Si);
  • The PUREVAP™ Nano Silicon Reactor (NSiR), a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires;
    °  HPQ believes it can also become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries;
    °  During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using PUREVAP™ SiNR.

HPQ is also working with industry leader Apollon Solar of France to:

  • Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders;
    °  The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid-state batteries and porous silicon powders for Li-ion batteries.
    °  The plan is to deliver porous Si wafer to a battery manufacturer (under NDA) for testing in 2020.

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders. 

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]

Hollister Bioscience’s $HOLL.ca 100% Owned Subsidiary #Venom Extracts Generates Record Monthly Revenue of $3.75 million CDN in May 2020 $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 7:18 AM on Thursday, June 11th, 2020
  • For the month of May 2020, Venom reports that it generated record revenue of CDN$ 3.75 million from its product line of Cannabis Concentrates, P.H.O Concentrates and Cartridges, representing the highest revenue Venom has achieved in a single month
  • As compared to May 2019, Venom’s revenue increased 163%. 

VANCOUVER, BC, June 11, 2020 - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) ( FRANKFURT: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 220 dispensaries throughout California, is pleased to announce that its 100% owned subsidiary Venom Extracts (“Venom“) generated record revenue and EBITDA for the month of May 2020. 

For the month of May 2020, Venom reports that it generated record revenue of CDN$ 3.75 million from its product line of Cannabis Concentrates, P.H.O Concentrates and Cartridges, representing the highest revenue Venom has achieved in a single month.  As compared to May 2019, Venom’s revenue increased 163%.  The Company cautions that revenue figures have not yet been audited and are based on reports prepared by Venom management.

“We are firing on all cylinders here at Venom” shared Jake Cohen, Founder of Venom Extracts.  “Having our best month ever in terms of revenue and EBITDA speaks to the resilience of our business model in the face of these uncertain times as well as the healthy customer demand for our product line.”

“We are very excited to see these record monthly revenues. We are looking forward to replicating Venom’s business model in our California facilities and beyond.” shared Carl Saling, CEO of Hollister Biosciences Inc.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products.  Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website: www.hollistercannabisco.com

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com